In metastatic melanoma, miR-222's promoter binds directly to ETS-1, where phosphorylation status influences its expression; conversely, non-phosphorylated ETS-1 in early melanoma suppresses miR-222 transcription [77]. This evidence concerns the gene ETS1 and metastatic melanoma.